Previous Article | Next Article 
Molecular and Cellular Biology, March 2001, p. 1828-1832, Vol. 21, No. 5
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.5.1828-1832.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Early Embryonic Lethality in PARP-1 Atm
Double-Mutant Mice Suggests a Functional Synergy in Cell Proliferation
during Development
Josiane Ménissier-de
Murcia,1,*
Manuel
Mark,2
Olivia
Wendling,2
Anthony
Wynshaw-Boris,3 and
Gilbert
de Murcia1
Ecole Supérieure de Biotechnologie de
Strasbourg, UPR 9003 du CNRS, Cancérogenèse et
Mutagenèse Moléculaire et
Structurale,1 and Institut de
Génétique et de Biologie Moléculaire et Cellulaire,
CNRS/INSERM/ULP, Collège de France,2 67400 Illkirch Cedex, France, and Genetic Disease Research Branch,
National Human Genome Research Institute, National Institutes of
Health, Bethesda, Maryland 208923
Received 7 November 2000/Accepted 10 November 2000
 |
ABSTRACT |
PARP-1 and ATM are both involved in the response to DNA strand
breaks, resulting in induction of a signaling network responsible for
DNA surveillance, cellular recovery, and cell survival. ATM interacts
with double-strand break repair pathways and induces signals resulting
in the control of the cell cycle-coupled checkpoints. PARP-1 acts as a
DNA break sensor in the base excision repair pathway of DNA. Mice with
mutations inactivating either protein show radiosensitivity and high
radiation-induced chromosomal aberration frequencies. Embryos carrying
double mutations of both PARP-1 and Atm genes
were generated. These mutant embryos show apoptosis in the embryo but
not in extraembryonic tissues and die at embryonic day 8.0, although
extraembryonic tissues appear normal for up to 10.5 days of gestation.
These results reveal a functional synergy between PARP-1 and ATM during
a period of embryogenesis when cell cycle checkpoints are not active
and the embryo is particularly sensitive to DNA damage. These results
suggest that ATM and PARP-1 have synergistic phenotypes due to the
effects of these proteins on signaling DNA damage and/or on distinct
pathways of DNA repair.
 |
INTRODUCTION |
To survey the integrity of their
genomes, eukaryotic cells have evolved a sophisticated network of
proteins that play important roles in cell cycle regulation,
stimulation of the DNA repair machinery, and alteration in the
expression of genes necessary for the cell's recovery, survival, or
apoptosis. Among these factors, PARP and ATM are both multidomain
proteins with multiple cellular substrates that play a critical
regulatory function in the coordination of the cellular processes of
DNA repair and cell cycle checkpoint control.
The involvement of PARP-1 in the base excision repair (BER) pathway has
been established in mice with genetic inactivation of PARP-1. Treatment
of PARP-1
/
mice with either alkylating
agents or
-irradiation, both of which trigger the BER pathway,
reveals an extreme sensitivity to and a high genomic instability in the
presence of both of them. Treatment with alkylating agents, which
activates PARP-1 in normal cells, causes
PARP-1
/
splenocytes to undergo apoptosis
extremely rapidly, with a stabilization of p53 (20). The
extreme sensitivity of PARP-1
/
cells to
these agents could be explained by the accumulation of unrepaired DNA
damage. This view is supported by the fact that PARP-1
/
cells have a considerably prolonged
delay of DNA strand break rejoining (3, 31). Whole-cell
extracts from a PARP-deficient cell line are specifically defective in
the polymerization step of the BER pathway (6, 7). In
vivo, PARP-1 is strongly associated with XRCC1, a DNA repair protein
linked to DNA polymerase
and DNA ligase III in the BER complex
(19). Therefore, PARP-1 appears to play a key role in
detecting DNA strand breaks and recruiting a DNA repair factor(s),
allowing the cell to repair in a window of time compatible with cell
cycle progression (24).
Ataxia telangiectasia (A-T) is a human autosomal recessive disorder
characterized by a pleiotropic phenotype that includes progressive
cerebellar degeneration, premature aging, cellular and humoral immune
defects, growth retardation, telangiectasia, high sensitivity to
ionizing radiation (IR), high incidence of cancer, and gonad atrophy.
At the cellular level, A-T is characterized by chromosomal instability,
radio-resistant DNA synthesis, hypersensitivity to IR (12,
27), and defects in recombinational repair (4, 22).
In addition A-T cells grow slowly and exhibit defective induction at
all checkpoints in response to DNA strand breaks. This may in part
reflect the fact that A-T cells exhibit delayed induction of p53 in an
IR-induced DNA damage-signaling pathway (14, 15, 34). The
gene consistently mutated in A-T patients, Atm, belongs to
the phosphatidylinositol 3'-kinase superfamily, a family of signal
transduction proteins which possess a serine/threonine protein kinase
activity (25, 35). Upon DNA damage, the ATM-p53-mediated checkpoint requires activated ATM, which in turn activates p53. Atm-deficient mice recapitulate the A-T phenotype in humans
(2, 4, 8, 33): they are sterile and exquisitely sensitive to IR.
ATM also regulates pathways important for DNA repair. Cell lines
established from Atm-deficient mice, like those from A-T patients, exhibit a defect in genomic stability as well as cell cycle
checkpoint abnormalities after IR (2). BRCA1 and NBS1 are
direct targets of ATM and participate directly in DNA repair pathways
(5, 10, 11, 17, 32, 36). It is unclear which phenotypes in
A-T patients or Atm-deficient mice are the result of defects
in checkpoint function or DNA repair. The phenotypes of each of the
single-mutant mice are likely attributed to the defect in sensing,
repairing, or signaling DNA breaks. The mechanisms by which PARP-1 and
ATM perform these various functions remain not totally characterized.
We therefore investigated the relationship between PARP-1 and ATM in
the whole animal. In this work, we show that the double mutation of
both Atm and PARP-1 genes in the mouse leads to
an early postimplantation lethality of the embryo at embryonic day 8.0 (E8.0), with extensive cell death in the embryo at E11.5. Since this
period of embryogenesis is one of extreme sensitivity to DNA damage due
to rapid proliferation and lack of checkpoints (13, 28),
these results suggest that PARP-1 and ATM act synergistically in
pathways that either monitor or repair DNA damage during mouse development.
 |
MATERIALS AND METHODS |
Mice.
PARP-1 and ATM single-mutant mouse lines have been
described previously (2, 20).
PARP-1
/
Atm
/
doubly null embryos were obtained by intercrosses of
PARP-1
/
Atm+/
mice.
Genotypes were determined by PCR on yolk sac DNA (primers and PCR
conditions are available upon request).
Histological analysis.
Decidua were collected in 10 mM
phosphate-buffered saline, pH 7.2, and then fixed in Bouin's fluid for
14 h, dehydrated, and embedded in paraffin. Serial sections (6 µm thick) were cut and stained with hematoxylin and eosin.
 |
RESULTS AND DISCUSSION |
PARP-1 and ATM are essential together for early embryonic
development.
Mice heterozygous for Atm (2)
were crossed with PARP-1
/
mice
(20) to produce animals heterozygous for both mutations. Doubly heterozygous mice (PARP+/
Atm+/
) were interbred to generate null mice
for both genotypes. No doubly homozygous mice were identified (not
shown). PARP-1
/
Atm+/
mice were generated; they were viable
and looked normal, but displayed an hypofertility phenotype (Table
1). PARP-1
/
Atm+/
mice were further intercrossed to
generate doubly homozygous mutants, but genotype analysis at term
(n = 123) failed to identify any animal of this
genotype, whereas PARP-1
/
Atm+/+ and PARP-1
/
Atm+/
mice were recovered in a 1:2 ratio.
Blastocysts (E3.5) were isolated from
PARP-1
/
Atm+/
intercrosses by uterine flushing and then genotyped by PCR.
Double-knockout (KO) embryos were detected at this stage, suggesting
that deficiency of both PARP-1 and ATM resulted in early
postimplantation embryonic lethality. Cumulative typing of litters at
different stages of gestation demonstrated that double-KO embryos
appeared up to E11.5 at a normal Mendelian ratio but displayed a severe
retardation in their development.
PARP-1
/
Atm
/
embryos die by apoptosis shortly after
the onset of gastrulation.
In order to determine the cause of the
death of the double-null mutants, litters from
PARP-1
/
Atm+/
intercrosses were analyzed at different developmental stages. The
earliest defects were observed at E8.0. Normal E8.0 embryos (i.e.,
PARP-1
/
Atm+/+ and
Atm+/
embryos) displayed prominent head folds
(Fig. 1a and e), a foregut pocket (Fig.
1e), and somites (Fig. 1e). The five
PARP-1
/
Atm
/
mutants genotyped at E8.0 were either severely growth retarded (compare
Fig. 1a and b) or appeared as empty yolk sacs (data not shown; see
below). Severely retarded E8.0 embryos analyzed on serial histological
sections (n = 3) were arrested at a stage equivalent to
E7.0, as they lacked head folds, a foregut pocket, and somites (Fig.
1f); had a persistent ectoplacental cavity (Fig. 1f); and already
displayed a mesoderm (Fig. 1h) as well as a small allantois (compare
Fig. 1e and f). However, these retarded embryos were markedly different
from normal E7.0 embryos due to the presence of numerous pycnotic and
fragmented nuclei, which were readily identifiable in the mesoderm and
amniotic cavity (compare Fig. 1g and h).

View larger version (57K):
[in this window]
[in a new window]
|
FIG. 1.
External views and histological sections of E8.0 and
E9.5 normal (N, not genotyped; PARP-1 /
Atm+/ [ / ;+/ ]) and PARP-1
Atm double-null ( / ; / ) conceptuses. The embryo in
panel c was taken out of its yolk sac. Abbreviations: A, amnion; AC,
amniotic cavity; AL, allantois; EC, ectoplacental cavity; EM, embryo;
F, foregut pocket; H, head folds; P, placenta; S, somites; Y, yolk sac;
YC, yolk sac cavity. Small arrows, condensed nuclear fragments. The
same magnifications were used for panels a and b and for panels c and
d. Scale bar (bar in panel h applies to panels e to h): 250 µm (e and
f) and 25 µm (g and h).
|
|
PARP-1
/
Atm
/
conceptuses genotyped at E9.5 (
n = 4), E10.5
(
n = 6), and E11.5 (
n = 2) appeared as
yolk sacs capped by the placenta
(compare Fig.
1d with 1c; data not
shown). At all these developmental
stages, the embryonic tissues were
replaced by a small mass of
disorganized and loosely arranged cells
(Fig.
2a and e) containing
a large
proportion of pycnotic and fragmented nuclei (about 30%
at E10.5
[
n = 2; Fig.
2b] and more than 90% at E11.5
[
n = 1; Fig.
2e and h]). In contrast, the ectodermal
and endodermal extraembryonic
cells of the
PARP-1
/
Atm
/
conceptuses, such as trophoblast cells (Fig.
2g) and parietal
and
visceral endodermal cells V (Fig.
2c, d, and f and data not
shown), did
not show apoptotic features. Along the same lines,
numerous healthy
primitive blood cells had differentiated within
the extraembryonic
mesoderm by E10.5 B (compare Fig.
2c and d).
However, in E11.5
PARP-1
/
Atm
/
mutants, the primitive blood islands were scarce and contained
numerous
apoptotic cells (Fig.
2f).

View larger version (136K):
[in this window]
[in a new window]
|
FIG. 2.
Histological and electron-microscopic analysis of E10.5
and E11.5 normal mice (N) and presumptive PARP-1
Atm double-null mutants ( / ; / ). Panels b and d
represent high magnifications of areas similar to those designated in
panel a by EM and Y, respectively. The inset in panel e is a
low-magnification view of the embryo and yolk sac displayed in panels e
and f. (b and d) Abnormal E10.5 embryos; (e to h) abnormal E11.5
embryos. Abbreviations: B, primitive blood islands; EM, embryo; M,
maternal blood sinus; P, placenta; T, trophoblast cell; V, visceral
endoderm; Y, visceral portion of the yolk sac; YC, yolk sac cavity.
Arrows, condensed nuclear fragments; double arrow, phagocytosis of one
of these fragments by an embryonic cell. Scale bar (bar in panel h
applies to all panels): 280 µm (a), 15 µm (b), 20 µm (c and d to
g), and 3 µm (h).
|
|
Altogether, these data indicate that
PARP-1
/
Atm
/
embryonic tissues undergo apoptosis
shortly after the onset of gastrulation
and that cell types that do not
directly participate in the formation
of the embryo are relatively more
resistant to the loss of both
PARP-1 and
ATM.
PARP-1 and Atm act in concert to preserve genomic integrity.
In mammals, during early postimplantation development, undifferentiated
stem cells that form the epiblast sustain a high cell division rate
(28). To ensure survival, a tight surveillance of genomic
integrity is required. Recently, it has been shown that wild-type
embryos exposed to low doses of X rays during gastrulation have a very
low threshold for DNA damage (13). During this restrictive developmental window, embryonic cells undergo apoptosis without cell
cycle arrest in response to a low dose of genotoxic stress. Interestingly, only embryonic cells become hypersensitive to DNA damage, not cells in the extraembryonic region. DNA damage might be
tolerated in these cells because they are transient and do not give
rise to critical lineages. Moreover, the same authors showed that
low-dose irradiation during early gastrulation of Atm-deficient embryos does not induce an apoptotic response
but that the embryos do not survive, demonstrating that (i)
Atm is a key element in preventing the activation of
apoptotic pathways and (ii) apoptosis is a safeguard mechanism to
preserve genomic integrity during the development (13).
As seen in any proliferative state, intense metabolism in embryonic
growth is accompanied by an oxidative burst that may cause
oxidative
damage to genomic DNA. In the double-mutant embryo both
PARP-1- and
ATM-mediated DNA repair and cell signaling of DNA
damage were
defective, leading to massive apoptosis of the embryo
at the onset of
gastrulation because of the dramatic sensitivity
to DNA damage during
this stage. That the extraembryonic tissue
was less severely affected
was likely due to a lower cell division
rate or to lower susceptibility
to apoptosis from persistent DNA
damage, as shown in IR-treated embryos
during gastrulation (
13).
Interestingly, similar embryonic lethality phenotypes at the
onset of gastrulation were observed in mutant embryos lacking
BER
factors, such as mutants lacking XRCC1 (
30) and APE (REF)
(
18), two proteins acting at different steps in the BER
pathway.
APE and REF carry out repair incision at a basic site,
allowing
DNA polymerase

to synthesize a short patch of DNA (for a
review
see reference
26) which is ligated by DNA ligase I
or III. XRCC1
is a scaffold protein linked to DNA polymerase

(
16), DNA ligase
III (
23), and PARP
(
19). XRCC1 plays a key role as a stimulator
of DNA ligase
III (
23) and as a negative regulator of PARP activity
(
19). All embryos suffered an overall developmental arrest
at
E7.5 to 8.5, whereas extraembryonic tissues appeared normal,
suggesting
that (i) these proteins are involved in the same pathway and
(ii)
the loss of ATM may exacerbate the BER deficiency in
PARP-1
/
cells.
We and others have previously shown that BER occurs to some extent in
PARP-1
/
cells but at a much lower rate than
in wild-type cells (
3,
6,
7,
31). PARP-1 is a member of a
growing family of PARP
proteins; among them, PARP-2 (
1),
another DNA damage-activated
PARP, would likely functionally compensate
for the lack of PARP-1.
A gene-targeted deficiency of
Pol
(
29), encoding DNA polymerase

, resulted in lethality
at E10.5, suggesting that other DNA polymerases
(e.g.,

and

)
have redundancy functions at least until midgestation.
It is
interesting that neither DNA glycosylase is necessary for
development
and survival in the mouse (reviewed in reference
9),
suggesting redundancy of function between these enzymes. Then,
a
generalized deficiency of BER would likely be lethal because
of
spontaneous accumulation of DNA strand breaks and
mutations.
BRCA1 and NBS1 are targets of ATM kinase activity (
5,
10,
11,
17,
32,
36). BRCA1-deficient embryos display a
lethal
phenotype similar to that due to the BER proteins (
9).
ATM
could play a role in regulating BRCA1 and NBS1 functions involved
in
multiple biological pathways that regulate cell cycle progression,
centrosome duplication, DNA damage repair, and apoptosis. As noted
above, homologous recombination is defective in
Atm
/
cells (
21) and mice
(
4). In consideration of these points,
the synergistic
phenotype displayed by
PARP-1 Atm double mutants
could be
interpreted in two ways: ATM and PARP-1 participate in
overlapping DNA
damage signaling pathways and/or PARP-1 and
Atm regulate
distinct forms of DNA repair that partially compensate
for each other.
Since PARP-1 and ATM participate in BER and homologoous
recombination,
respectively, we favor the latter
interpretation.
In conclusion, our results shed light on the consequence of the
disruption of two important pathways for the surveillance
of the genome
during cell proliferation (Fig.
3) and
identify
PARP and ATM as "integrators" of signals emerging from DNA
strand-breaks
and suggest that a limited functional compensation is not
excluded
during cell proliferation since the loss of both pathways
exacerbates
the phenotype of loss of either pathway.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 3.
Signal transduction pathways leading to DNA repair and
checkpoint induction by PARP-1 and Atm. PARP-1 is activated
by breaks in DNA and is likely to recruit XRCC1 and the BER complex on
the site of the lesion, allowing efficient DNA repair and cell cycle
progression. ATM, a DNA double-stranded break enzyme,
phosphorylates p53 specifically to selectively induce
G1 arrest via p21 transcription.
|
|
 |
ACKNOWLEDGMENTS |
We are grateful to P. Chambon for his constant support, and to A. Huber, A. Gansmüller, and M. C. Hummel for excellent
technical assistance.
This work was supported by the Association pour la Recherche contre le
Cancer, the Ligue contre le Cancer, Electricité de France, the
Commissariat à l'Energie Atomique, and Fondation pour la
Recherche Médicale.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: UPR 9003 du
CNRS, Laboratoire conventionné avec le Commissariat à
l'Energie Atomique, Ecole Supérieure de Biotechnologie de
Strasbourg, Boulevard Sébastien Brant, 67400 Illkirch, France.
Phone: (33) 388 65 53 64. Fax: (33) 388 65 53 52. E-mail:
josiane{at}esbs.u-strasbg.fr.
 |
REFERENCES |
| 1.
|
Ame, J. C.,
V. Rolli,
V. Schreiber,
C. Niedergang,
F. Apiou,
P. Decker,
S. Muller,
T. Hoger,
J. Menissier-de Murcia, and G. de Murcia.
1999.
PARP-2, a novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase.
J. Biol. Chem.
274:17860-17868[Abstract/Free Full Text].
|
| 2.
|
Barlow, C.,
S. Hirotsune,
R. Paylor,
M. Liyanage,
M. Eckhaus,
F. Collins,
Y. Shiloh,
J. N. Crawley,
T. Ried,
D. Tagle, and A. Wynshaw-Boris.
1996.
Atm-deficient mice: a paradigm of ataxia telangectasia.
Cell
86:159-171[CrossRef][Medline].
|
| 3.
|
Beneke, R.,
C. Geisen,
B. Zevnik,
T. Bauch,
W. U. Muller,
J. H. Kupper, and T. Moroy.
2000.
DNA excision repair and DNA damage-induced apoptosis are linked to poly(ADP-ribosyl)ation but have different requirements for p53.
Mol. Cell. Biol.
20:6695-6703[Abstract/Free Full Text].
|
| 4.
|
Bishop, A. J.,
C. Barlow,
A. J. Wynshaw-Boris, and R. H. Schiestl.
2000.
Atm deficiency causes an increased frequency of intrachromosomal homologous recombination in mice.
Cancer Res.
60:395-399[Abstract/Free Full Text].
|
| 5.
|
Cortez, D.,
Y. Wang,
J. Qin, and S. J. Elledge.
1999.
Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.
Science
286:1162-1166[Abstract/Free Full Text].
|
| 6.
|
Dantzer, F.,
G. De La Rubia,
J. Menissier-de Murcia,
Z. Hostomsky,
G. de Murcia, and V. Schreiber.
2000.
Base excision repair is impaired in mammalian cells lacking poly(ADP-ribose) polymerase-1.
Biochemistry
39:7559-7569[CrossRef][Medline].
|
| 7.
|
Dantzer, F.,
V. Schreiber,
C. Niedergang,
C. Trucco,
E. Flatter,
G. De La Rubia,
J. Oliver,
V. Rolli,
J. Menissier-de Murcia, and G. de Murcia.
1999.
Involvement of poly(ADP-ribose) polymerase in base excision repair.
Biochimie
81:69-75[Medline].
|
| 8.
|
Elson, A.,
Y. Wang,
C. J. Daugherty,
C. C. Morton,
F. Zhou,
J. Campos-Torres, and P. Leder.
1996.
Pleiotropic defects in ataxia-telangiectasia protein-deficient mice.
Proc. Natl. Acad. Sci. USA
93:13084-13089[Abstract/Free Full Text].
|
| 9.
|
Friedberg, E. C., and L. B. Meira.
1999.
Database of mouse strains carrying targeted mutations in genes affecting cellular responses to DNA damage: version 3.
Mutat. Res.
433:69-87[Medline].
|
| 10.
|
Gatei, M.,
S. P. Scott,
I. Filippovitch,
N. Soronika,
M. F. Lavin,
B. Weber, and K. K. Khanna.
2000.
Role for ATM in DNA damage-induced phosphorylation of BRCA1.
Cancer Res.
60:3299-3304[Abstract/Free Full Text].
|
| 11.
|
Gatei, M.,
D. Young,
K. M. Cerosaletti,
A. Desai-Mehta,
K. Spring,
S. Kozlov,
M. F. Lavin,
R. A. Gatti,
P. Concannon, and K. Khanna.
2000.
ATM-dependent phosphorylation of nibrin in response to radiation exposure.
Nat. Genet.
25:115-119[CrossRef][Medline].
|
| 12.
|
Halazonetis, T. D., and Y. Shiloh.
1999.
Many faces of ATM: eighth international workshop on ataxia-telangiectasia.
Biochim. Biophys. Acta
1424:R45-R55[Medline].
|
| 13.
|
Heyer, B. S.,
A. MacAuley,
O. Behrendtsen, and Z. Werb.
2000.
Hypersensitivity to DNA damage leads to increased apoptosis during early mouse development.
Genes Dev.
14:2072-2084[Abstract/Free Full Text].
|
| 14.
|
Kastan, M. B.,
Q. Zhan,
W. S. El-Deiry,
F. Carrier,
T. Jacks,
W. V. Walsh,
B. S. Plunkett,
B. Vogelstein, and A. J. Fornace.
1992.
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia telangiectasia.
Cell
71:587-598[CrossRef][Medline].
|
| 15.
|
Khanna, K. K., and M. F. Lavin.
1993.
Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells.
Oncogene
8:3307-3312[Medline].
|
| 16.
|
Kubota, Y.,
R. A. Nash,
A. Klungland,
P. Schar,
D. E. Barnes, and T. Lindahl.
1996.
Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein.
EMBO J.
15:6662-6670[Medline].
|
| 17.
|
Lim, D. S.,
S. T. Kim,
B. Xu,
R. S. Maser,
J. Lin,
J. H. Petrini, and M. B. Kastan.
2000.
ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway.
Nature
404:613-617[CrossRef][Medline].
|
| 18.
|
Ludwig, D. L.,
M. A. MacInnes,
Y. Takiguchi,
P. E. Purtymun,
M. Henrie,
M. Flannery,
J. Meneses,
R. A. Pedersen, and D. J. Chen.
1998.
A murine AP-endonuclease gene-targeted deficiency with post-implantation embryonic progression and ionizing radiation sensitivity.
Mutat. Res.
409:17-29[Medline].
|
| 19.
|
Masson, M.,
C. Niedergang,
V. Schreiber,
S. Muller,
J. Menissier-de Murcia, and G. de Murcia.
1998.
XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage.
Mol. Cell. Biol.
18:3563-3571[Abstract/Free Full Text].
|
| 20.
|
Ménissier-de Murcia, J.,
C. Niedergang,
C. Trucco,
M. Ricoul,
B. Dutrillaux,
M. Mark,
F. J. Olivier,
M. Masson,
A. Dierich,
M. LeMeur,
C. Walztinger,
P. Chambon, and G. de Murcia.
1997.
Requirement of poly(ADP-ribose)- polymerase in recovery from DNA damage in mice and in cells.
Proc. Natl. Acad. Sci. USA
94:7303-7307[Abstract/Free Full Text].
|
| 21.
|
Morrison, C.,
E. Sonoda,
N. Takao,
A. Shinohara,
K. Yamamoto, and S. Takeda.
2000.
The controlling role of ATM in homologous recombinational repair of DNA damage
EMBO J.
19:463-471[CrossRef][Medline]. (Erratum, 19:786.)
|
| 22.
|
Morrison, C., and E. Wagner.
1996.
Extrachromosomal recombination occurs efficiently in cells defective in various DNA repair systems.
Nucleic Acids Res.
24:2053-2058[Abstract/Free Full Text].
|
| 23.
|
Nash, R. A.,
K. W. Caldecott,
D. E. Barnes, and T. Lindahl.
1997.
XRCC1 protein interacts with one of two distinct forms of DNA ligase III.
Biochemistry
36:5207-5211[CrossRef][Medline].
|
| 24.
|
Oliver, F. J.,
J. Menissier-de Murcia, and G. de Murcia.
1999.
Poly(ADP-ribose) polymerase in the cellular response to DNA damage, apoptosis, and disease.
Am. J. Hum. Genet.
64:1282-1288[CrossRef][Medline].
|
| 25.
|
Savitsky, K.,
A. Bar Shira,
S. Gliad,
G. Rotman,
Y. Ziv,
L. Vnagaite, and D. A. Tagle.
1995.
A single ataxia telangiectasia gene with a product similar to PI-3 kinase.
Science
268:1749-1753[Abstract/Free Full Text].
|
| 26.
|
Seeberg, E.,
L. Eide, and M. Bjoras.
1995.
The base excision repair pathway.
Trends Biochem. Sci.
20:391-397[CrossRef][Medline].
|
| 27.
|
Shiloh, Y.
1998.
Ataxia-telangiectasia, ATM and genomic stability: maintaining a delicate balance. Two international workshops on ataxia-telangiectasia, related disorders and the ATM protein.
Biochim. Biophys. Acta
1378:R11-R18[Medline].
|
| 28.
|
Snow, M. H. L.
1977.
Gastrulation in the mouse: growth and regionalisation of the epiblast.
J. Embryol. Exp. Morphol.
42:293-303.
|
| 29.
|
Sobol, R. W.,
J. K. Horton,
R. Kuhn,
H. Gu,
R. K. Singhal,
R. Prasad,
K. Rajewsky, and S. H. Wilson.
1996.
Requirement of mammalian DNA polymerase beta in base excision repair.
Nature
379:183-186[CrossRef][Medline].
|
| 30.
|
Tebbs, R. S.,
M. L. Flannery,
J. J. Meneses,
A. Hartmann,
J. D. Tucker,
L. H. Thompson,
J. E. Cleaver, and R. A. Pedersen.
1999.
Requirement for the Xrcc1 DNA base excision repair gene during early mouse development.
Dev. Biol.
208:513-529[CrossRef][Medline].
|
| 31.
|
Trucco, C.,
F. J. Oliver,
G. de Murcia, and J. Menissier-de Murcia.
1998.
DNA repair defect in poly(ADP-ribose) polymerase-deficient cell lines.
Nucleic Acids Res.
26:2644-2649[Abstract/Free Full Text].
|
| 32.
|
Wu, X.,
V. Ranganathan,
D. S. Weisman,
W. F. Heine,
D. N. Ciccone,
T. B. O'Neill,
K. E. Crick,
K. A. Pierce,
W. S. Lane,
G. Rathbun,
D. M. Livingston, and D. T. Weaver.
2000.
ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response.
Nature
405:477-482[CrossRef][Medline].
|
| 33.
|
Xu, Y.,
T. Ashley,
E. E. Brainerd,
R. T. Bronson,
M. S. Meyn, and D. Baltimore.
1996.
Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma.
Genes Dev.
10:2411-2422[Abstract/Free Full Text].
|
| 34.
|
Xu, Y., and D. Baltimore.
1996.
Dual roles of ATM in the cellular response to radiation and in cell control.
Genes Dev.
10:2401-2410[Abstract/Free Full Text].
|
| 35.
|
Zakian, V. A.
1995.
ATM-related genes: what do they tell us about functions of the human gene?
Cell
82:685-687[CrossRef][Medline].
|
| 36.
|
Zhao, S.,
Y. C. Weng,
S. S. Yuan,
Y. T. Lin,
H. C. Hsu,
S. C. Lin,
E. Gerbino,
M. H. Song,
M. Z. Zdzienicka,
R. A. Gatti,
J. W. Shay,
Y. Ziv,
Y. Shiloh, and E. Y. Lee.
2000.
Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products.
Nature
405:473-477[CrossRef][Medline].
|
Molecular and Cellular Biology, March 2001, p. 1828-1832, Vol. 21, No. 5
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.5.1828-1832.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Robert, I., Dantzer, F., Reina-San-Martin, B.
(2009). Parp1 facilitates alternative NHEJ, whereas Parp2 suppresses IgH/c-myc translocations during immunoglobulin class switch recombination. JEM
206: 1047-1056
[Abstract]
[Full Text]
-
Haince, J.-F., Kozlov, S., Dawson, V. L., Dawson, T. M., Hendzel, M. J., Lavin, M. F., Poirier, G. G.
(2007). Ataxia Telangiectasia Mutated (ATM) Signaling Network Is Modulated by a Novel Poly(ADP-ribose)-dependent Pathway in the Early Response to DNA-damaging Agents. J. Biol. Chem.
282: 16441-16453
[Abstract]
[Full Text]
-
Bryant, H. E., Helleday, T.
(2006). Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair. Nucleic Acids Res
34: 1685-1691
[Abstract]
[Full Text]
-
Zheng, P., Schramm, R. D., Latham, K. E.
(2005). Developmental Regulation and In Vitro Culture Effects on Expression of DNA Repair and Cell Cycle Checkpoint Control Genes in Rhesus Monkey Oocytes and Embryos. Biol. Reprod.
72: 1359-1369
[Abstract]
[Full Text]
-
Shima, N., Munroe, R. J., Schimenti, J. C.
(2004). The Mouse Genomic Instability Mutation chaos1 Is an Allele of Polq That Exhibits Genetic Interaction with Atm. Mol. Cell. Biol.
24: 10381-10389
[Abstract]
[Full Text]
-
Ishizuka, S., Martin, K., Booth, C., Potten, C. S., de Murcia, G., Burkle, A., Kirkwood, T. B. L.
(2003). Poly(ADP-ribose) polymerase-1 is a survival factor for radiation-exposed intestinal epithelial stem cells in vivo. Nucleic Acids Res
31: 6198-6205
[Abstract]
[Full Text]
-
Tartier, L., Spenlehauer, C., Newman, H. C., Folkard, M., Prise, K. M., Michael, B. D., Menissier-de Murcia, J., de Murcia, G.
(2003). Local DNA damage by proton microbeam irradiation induces poly(ADP-ribose) synthesis in mammalian cells. Mutagenesis
18: 411-416
[Abstract]
[Full Text]
-
Tong, W.-M., Cortes, U., Hande, M. P., Ohgaki, H., Cavalli, L. R., Lansdorp, P. M., Haddad, B. R., Wang, Z.-Q.
(2002). Synergistic Role of Ku80 and Poly(ADP-ribose) Polymerase in Suppressing Chromosomal Aberrations and Liver Cancer Formation. Cancer Res.
62: 6990-6996
[Abstract]
[Full Text]
-
Masutani, M., Miwa, M.
(2002). Poly(ADP-ribose) Polymerase and Cancer: In Relation to the Lectures Presented by Dr Gilbert de Murcia. Jpn J Clin Oncol
32: 483-487
[Full Text]
-
Lee, Y., Chong, M. J., McKinnon, P. J.
(2001). Ataxia Telangiectasia Mutated-Dependent Apoptosis after Genotoxic Stress in the Developing Nervous System Is Determined by Cellular Differentiation Status. J. Neurosci.
21: 6687-6693
[Abstract]
[Full Text]